How have NVTRQ shares performed in 2024?

Nuvectra's stock was trading at $0.0150 at the beginning of the year. Since then, NVTRQ stock has increased by 0.0% and is now trading at $0.0150. View the best growth stocks for 2024 here .

How were Nuvectra's earnings last quarter?

Nuvectra Corp (OTCMKTS:NVTRQ) posted its earnings results on Monday, October, 29th. The company reported ($0.87) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.86) by $0.01. The firm had revenue of $14.22 million for the quarter, compared to analyst estimates of $12.38 million.

How do I buy shares of Nuvectra?

Shares of NVTRQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:NVTRQ

Nuvectra (NVTRQ) Stock Price, News & Analysis

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Free NVTRQ Stock Alerts

$0.02

-0.01 (-25.00%)

(As of 06/2/2020)

Compare

Today's Range: $0.02
▼
$0.02
50-Day Range: $0.0150
▼
$0.0150
52-Week Range: $0.01
▼
$4.30

Volume: 382,600 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Nuvectra alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Nuvectra Stock (OTCMKTS:NVTRQ)

Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs. It is also developing Virtis, a sacral neuromodulation (SNM) system for the treatment of chronic urinary retention and overactive bladder; and technologies to support other indications, including SNM for the treatment of overactive bladder and deep brain stimulation to treat Parkinson's disease. The company serves hospitals, surgery centers, and medical facilities through a direct sales force and third-party distributors in the United States and Europe. Nuvectra Corporation was founded in 2008 and is headquartered in Plano, Texas.

NVTRQ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NVTRQ Stock News Headlines

April 13, 2024 | americanbankingnews.com

Nuvectra (OTCMKTS:NVTRQ) Stock Price Passes Below Fifty Day Moving Average of $0.02

August 1, 2023 | investing.com

Imasen Electric Industrial Co Ltd (7266)

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 4, 2022 | benzinga.com

Global Nerve Repair & Regeneration Market (2021 to 2026) - by Product, Application and Geography - Benzin - Benzinga

March 2, 2022 | businesswire.com

Outlook on the Nerve Repair & Regeneration Global Market to 2026 - Featuring Medtronic, Abbott Laboratories and LivaNova Among Others - ResearchAndMarkets.com - Business Wire

February 17, 2022 | globenewswire.com

Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2021 - GlobeNewswire

February 17, 2022 | stockhouse.com

Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2021 - Stockhouse

February 15, 2022 | benzinga.com

Global Bioelectric Medicine Market (2020 to 2030) - by Product Type, End-user and Region - Benzinga - Benzinga

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

February 8, 2022 | globenewswire.com

Global Spinal Cord Stimulation Market (2021 to 2026) - by Product, Disease, End-user and Geography - GlobeNewswire

December 20, 2021 | benzinga.com

Global Spinal Cord Stimulation Market Research Report 2021 - Benzinga - Benzinga

December 15, 2021 | streetinsider.com

Form DEF 14A MERIDIAN BIOSCIENCE INC For: Jan 26 - StreetInsider.com

October 28, 2021 | globenewswire.com

Integer Holdings Corporation Reports Third Quarter 2021 Results - GlobeNewswire

September 17, 2021 | bizjournals.com

After 3 years without a CEO, Redmond startup Kymeta formalizes leadership structure - Puget Sound Business Journal (Seattle)

July 29, 2021 | globenewswire.com

Integer Holdings Corporation Reports Second Quarter 2021 Results - GlobeNewswire

See More Headlines

Receive NVTRQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuvectra and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/29/2018
Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: OTCMKTS:NVTRQ
Previous Symbol: NASDAQ:NVTRV
CUSIP: N/A
CIK: 1648893
Web: www.nuvectramed.com
Phone: 214-474-3103
Fax: N/A
Employees: 197
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Dr. Fred B. Parks Ph.D. (Age 72)
CEO & Director
Mr. Joseph Paul Hanchin (Age 57)
Pres
Mr. Walter Z. Berger (Age 63)
COO, CFO & Exec. VP
Ms. Jennifer J. Kosharek (Age 38)
VP, Controller & Principal Accounting Officer
Mr. Benjamin Tranchina
Chief Technology Officer

Key Competitors

View All Competitors

NVTRQ Stock Analysis - Frequently Asked Questions

How have NVTRQ shares performed in 2024?: Nuvectra's stock was trading at $0.0150 at the beginning of the year. Since then, NVTRQ stock has increased by 0.0% and is now trading at $0.0150.
View the best growth stocks for 2024 here.
How were Nuvectra's earnings last quarter?: Nuvectra Corp (OTCMKTS:NVTRQ) posted its earnings results on Monday, October, 29th. The company reported ($0.87) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.86) by $0.01. The firm had revenue of $14.22 million for the quarter, compared to analyst estimates of $12.38 million.
How do I buy shares of Nuvectra?: Shares of NVTRQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NVTRQ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial